This article is more than 5 years old. Information may no longer be current.

BME launches new intramedullary fixation solution

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BME recently announced the domestic launch of the HammerLock 2, the company’s new intramedullary fixation system. 

Featuring Nitinol technology, the HammerLock 2 provides surgeons an intramedullary implant for hammertoe fixation that does not require freezing, according to a company press release.

The system comes in presterilized and completely disposable implant and instrument kits and is designed to fit a wide range of anatomies.

Patent is pending for the HammerLock 2 implant and system, which is currently available for commercial use throughout the U.S., according to the release.

Resource: www.bme-tx.com.